Abbott ($ABT) made separate announcements related to devices focused on the eyes. The first was for a deal it reached with Carl Zeiss Meditec to sell the Swiss lensmaker’s cataract surgery products alongside its own ocular surgery devices.
I have been building forums to promote the life sciences community for over 10 years. I enjoy exploring the issues, individuals and companies impacting the life/med/health tech community, and celebrating the innovators, entrepreneurs and policy makers who are actively working to build the community.
Philips ($PHG) shed as much as 4% in early trading as continued manufacturing problems and intellectual property litigation as well as weakness in Russia and China weighed on investor confidence after it reported third-quarter results. The conglomerate had a net loss of €103 million ($132 million) on sales of €5.5 billion in the third quarter,…
Endotronix has been announced as one of the 11 finalist in the Nokia Sensing XCHALLENGE! Three members of the Endotronix executive team will travel to Los Angeles to present to the judges on November 5th. But the chance to win the competition isn’t only in the hands of the judges! 10% of the overall score will…
What’s two extra years of exclusivity worth? Enough to spark a legal fight. The FDA posted new guidance on its website Friday, awarding certain combo meds 5 years of exclusivity compared with the previous three. Drugmakers had lobbied for the change, but the timing–and the wording–are bound to be controversial.
The acquisition of dialysis company Gambro last September continues to fuel Baxter International’s ($BAX) sales growth as it preps to spin out its biopharma division in 2015. But despite some stop-gap measures, it’s not likely that Baxter will actually be able to meet the demand for its dialysis products until additional manufacturing capacity opens up in 2016.
Mercom Capital Group, llc, a global communications and consulting firm, today released its report on funding and mergers and acquisitions (M&A) activity in the Healthcare Information Technology (IT) sector for the third quarter of 2014. Mercom’s comprehensive report covers deals of all sizes in Healthcare IT across the globe.